{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:00:53Z","timestamp":1793156453635,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073772"],"award-info":[{"award-number":["82073772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260578"],"award-info":[{"award-number":["82260578"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20210324122214040"],"award-info":[{"award-number":["JCYJ20210324122214040"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2025A0505020041"],"award-info":[{"award-number":["2025A0505020041"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016077","name":"Dongguan Science and Technology Bureau","doi-asserted-by":"publisher","award":["20221800905702"],"award-info":[{"award-number":["20221800905702"]}],"id":[{"id":"10.13039\/501100016077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1515140044"],"award-info":[{"award-number":["2021B1515140044"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2026A1515012480"],"award-info":[{"award-number":["2026A1515012480"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010613"],"award-info":[{"award-number":["2023A1515010613"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jconrel.2026.114990","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:22:57Z","timestamp":1778023377000},"page":"114990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A biomimetic phase-separating hydrogel potentiates local chemo-virotherapy to eradicate recurrent glioblastoma"],"prefix":"10.1016","volume":"395","author":[{"given":"Yajie","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyan","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqiu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jconrel.2026.114990_bb0005","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"issue":"5 Suppl","key":"10.1016\/j.jconrel.2026.114990_bb0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1188\/16.CJON.S1.2-8","article-title":"Glioblastoma: overview of disease and treatment","volume":"20","author":"Davis","year":"2016","journal-title":"Clin. J. Oncol. Nurs."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114990_bb0015","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/cncr.26494","article-title":"Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of surveillance, epidemiology, and end results registries","volume":"118","author":"Darefsky","year":"2012","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114990_bb0020","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","article-title":"Association of the Extent of resection with survival in glioblastoma: a systematic review and Meta-analysis","volume":"2","author":"Brown","year":"2016","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114990_bb0025","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro-Oncology"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114990_bb0030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of immunotherapy resistance: lessons from glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat. Immunol."},{"issue":"6605","key":"10.1016\/j.jconrel.2026.114990_bb0035","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.abn7570","article-title":"Mechanism-based design of agents that selectively target drug-resistant glioma","volume":"377","author":"Lin","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114990_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114990_bb0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114990_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404965","article-title":"Oncolytic virus targeted therapy for glioma via intravenous delivery","volume":"14","author":"He","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114990_bb0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s40259-022-00553-7","article-title":"Teserpaturev\/G47\u0394: first approval","volume":"36","author":"Frampton","year":"2022","journal-title":"Biodrugs"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114990_bb0060","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41591-023-02347-y","article-title":"Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1\/2 trial","volume":"29","author":"Nassiri","year":"2023","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114990_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002086","article-title":"Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy","volume":"9","author":"Shin","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114990_bb0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114990_bb0075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114990_bb0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s42003-023-04983-z","article-title":"Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogel","volume":"6","author":"Zhuang","year":"2023","journal-title":"Commun Biol"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114990_bb0085","article-title":"Emerging delivery strategy for oncolytic virotherapy","volume":"32","author":"Zhu","year":"2024","journal-title":"Mol Ther Oncol"},{"issue":"32","key":"10.1016\/j.jconrel.2026.114990_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202401745","article-title":"Mucus-inspired self-healing hydrogels: a protective barrier for cells against viral infection","volume":"36","author":"Bej","year":"2024","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114990_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061541","article-title":"Oncolytic herpes simplex virus-based therapies for Cancer","volume":"10","author":"Aldrak","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114990_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41392-025-02343-3","article-title":"Oncolytic viruses: advanced strategies in cancer therapy","volume":"11","author":"Xiao","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114990_bb0105","article-title":"Advances in preclinical and clinical studies of oncolytic virus combination therapy","volume":"15","author":"Du","year":"2025","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114990_bb0110","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114990_bb0115","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/mt.2011.39","article-title":"Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy","volume":"19","author":"Heo","year":"2011","journal-title":"Mol. Ther."},{"issue":"23","key":"10.1016\/j.jconrel.2026.114990_bb0120","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.7150\/thno.49480","article-title":"Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114990_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/cgt.2012.97","article-title":"Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis","volume":"20","author":"Kulu","year":"2013","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114990_bb0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41392-021-00678-1","article-title":"Liquid-liquid phase separation in human health and diseases","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114990_bb0135","doi-asserted-by":"crossref","DOI":"10.1021\/acsabm.2c00640","article-title":"Liquid-liquid phase-separated hydrogel with tunable sol-gel transition behavior as a Hotmelt-adhesive postoperative barrier","author":"Nishiguchi","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2026.114990_bb0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actbio.2024.05.024","article-title":"An artificial liquid-liquid phase separation-driven silk fibroin-based adhesive for rapid hemostasis and wound sealing","volume":"182","author":"Zhu","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114990_bb0145","article-title":"Transplantation of active mitochondria condensed in liquid\u2212liquid phase-separated hydrogels ameliorates myocardial ischemia-reperfusion injury","author":"Ai","year":"2025","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114990_bb0150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41428-025-01028-6","article-title":"Self-assembled nanofibers and hydrogels of double-hydrophobic elastin-like polypeptides formed via coacervation","volume":"57","author":"Sugawara-Narutaki","year":"2025","journal-title":"Polym. J."},{"issue":"17","key":"10.1016\/j.jconrel.2026.114990_bb0155","doi-asserted-by":"crossref","first-page":"14336","DOI":"10.1021\/jacs.5c00079","article-title":"Liquid-liquid phase separation-mediated cellular-scale compartmentalization of hydrogel covalent cross-linking promotes microtubule-based Mechanosensing","volume":"147","author":"Zhao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114990_bb0160","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.tim.2022.06.005","article-title":"Phase separation in viral infections","volume":"30","author":"Li","year":"2022","journal-title":"Trends Microbiol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114990_bb0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00705-026-06607-3","article-title":"Liquid-liquid phase separation in the viral replication cycle: new paradigms and therapeutic opportunities","volume":"171","author":"Sanjida","year":"2026","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jconrel.2026.114990_bb0170","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2024.08.033","article-title":"An oil-in-gel type of organohydrogel loaded with methylprednisolone for the treatment of secondary injuries following spinal cord traumas","volume":"374","author":"Tan","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114990_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122645","article-title":"Chitosan\/dextran-based organohydrogel delivers EZH2 inhibitor to epigenetically reprogram chemo\/immuno-resistance in unresectable metastatic melanoma","volume":"346","author":"Tang","year":"2024","journal-title":"Carbohydr. Polym."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114990_bb0180","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1158\/1078-0432.CCR-17-2954","article-title":"Toxicity and efficacy of a novel GADD34-expressing oncolytic HSV-1 for the treatment of experimental glioblastoma","volume":"24","author":"Nakashima","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114990_bb0185","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1038\/s41598-020-61736-2","article-title":"Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses","volume":"10","author":"Alayo","year":"2020","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.jconrel.2026.114990_bb0190","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1111\/j.1742-4658.2008.06655.x","article-title":"Role for nectin-1 in herpes simplex virus 1 entry and spread in human retinal pigment epithelial cells","volume":"275","author":"Tiwari","year":"2008","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114990_bb0195","doi-asserted-by":"crossref","first-page":"21396","DOI":"10.1038\/s41598-021-00889-0","article-title":"EZH1\/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma","volume":"11","author":"Kusakabe","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114990_bb0200","article-title":"Phase I\/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02","volume":"2","author":"Chen","year":"2020","journal-title":"Neurooncol. Adv."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114990_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10663","article-title":"Vaccine adjuvants for infectious disease in the clinic","volume":"9","author":"Goetz","year":"2024","journal-title":"Bioeng. Transl. Med."},{"issue":"13","key":"10.1016\/j.jconrel.2026.114990_bb0210","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.addr.2007.08.007","article-title":"Cell responses to the mechanochemical microenvironment--implications for regenerative medicine and drug delivery","volume":"59","author":"Rehfeldt","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114990_bb0215","article-title":"Flexible, penetrating brain probes enabled by advances in polymer microfabrication","volume":"7","author":"Weltman","year":"2016","journal-title":"Micromachines (Basel)"},{"issue":"31","key":"10.1016\/j.jconrel.2026.114990_bb0220","doi-asserted-by":"crossref","first-page":"28632","DOI":"10.1074\/jbc.M505196200","article-title":"Fusogenic domains in herpes simplex virus type 1 glycoprotein H","volume":"280","author":"Galdiero","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114990_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.454","article-title":"Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31","volume":"5","author":"Zhang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.114990_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217010","article-title":"Methylation synthetic lethality: exploiting selective drug targets for cancer therapy","volume":"597","author":"Ye","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114990_bb0235","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/JVI.03052-14","article-title":"Inhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of Herpes Simplex Virus 1 in trigeminal ganglion neurons","volume":"89","author":"Messer","year":"2015","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114990_bb0240","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01141-17","article-title":"Inhibitors of the histone methyltransferases EZH2\/1 induce a potent antiviral state and suppress infection by diverse viral pathogens","volume":"8","author":"Arbuckle","year":"2017","journal-title":"mBio"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114990_bb0245","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202304106","article-title":"HSV-1 exploits host heterochromatin for nuclear egress","volume":"222","author":"Lewis","year":"2023","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114990_bb0250","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52687","article-title":"Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway","volume":"9","author":"Kim","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114990_bb0255","article-title":"Mouse models of glioblastoma for the evaluation of novel therapeutic strategies","volume":"3","author":"Haddad","year":"2021","journal-title":"Neurooncol. Adv."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:06:29Z","timestamp":1783148789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"alternative-id":["S0168365926003937"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114990","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A biomimetic phase-separating hydrogel potentiates local chemo-virotherapy to eradicate recurrent glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114990"}}